-
Something wrong with this record ?
Microgradient separation technique for purification and fractionation of permethylated N-glycans before mass spectrometric analyses
P. Rehulka, M. Zahradnikova, H. Rehulkova, P. Dvorakova, R. Nenutil, D. Valik, B. Vojtesek, L. Hernychova, MV. Novotny,
Language English Country Germany
Document type Journal Article
- MeSH
- Chemical Fractionation MeSH
- Chromatography, Liquid MeSH
- Chromatography MeSH
- Spectrometry, Mass, Electrospray Ionization MeSH
- Humans MeSH
- Methylation MeSH
- Biomarkers, Tumor blood MeSH
- Ovarian Neoplasms blood MeSH
- Polysaccharides analysis MeSH
- Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization MeSH
- Healthy Volunteers MeSH
- Check Tag
- Humans MeSH
- Female MeSH
- Publication type
- Journal Article MeSH
Analysis of N-glycans released enzymatically from patients' sera or other clinical samples may provide diagnostically and prognostically important information on human disease. Permethylation of these biomolecules simultaneously increases their hydrophobicity and substantially improves their detection parameters in the following mass spectrometric analyses. The overall procedure, from the glycan cleavage to the final mass spectrometric determinations, includes several steps involving extraction, derivatization, and purification. During these steps, certain polymeric contaminants that may have been coincidentally introduced could hamper the final measurements. To understand and counter these interferences and further fractionate or preconcentrate these glycans, we introduce here an effective microgradient chromatographic technique that employs a small reversed-phase microcolumn connected to a gas-tight microsyringe delivering a mobile-phase gradient. After loading the glycan fraction onto the microcolumn, three elution steps are recommended: (1) remove polar contaminants; (2) recover permethylated glycans for either liquid chromatography with electrospray ionization mass spectrometry or matrix-assisted laser desorption/ionization mass spectrometry; and (3) remove larger polymeric contaminants and regenerate the precolumn. We further demonstrate that the trapped second fraction can be beneficially preconcentrated and further separated to achieve matrix-assisted laser desorption/ionization mass spectrometric detection of the derivatized N-glycans up to 6300 Da. The enhanced detection capabilities for tetra-antennary N-glycans are of increasing interest in disease biomarker discovery.
Regional Centre for Applied Molecular Oncology Masaryk Memorial Cancer Institute Brno Czech Republic
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc19000945
- 003
- CZ-PrNML
- 005
- 20191024094728.0
- 007
- ta
- 008
- 190107s2018 gw f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1002/jssc.201701339 $2 doi
- 035 __
- $a (PubMed)29392831
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a gw
- 100 1_
- $a Rehulka, Pavel $u Department of Molecular Pathology and Biology, Faculty of Military Health Sciences, University of Defence, Hradec Kralove, Czech Republic.
- 245 10
- $a Microgradient separation technique for purification and fractionation of permethylated N-glycans before mass spectrometric analyses / $c P. Rehulka, M. Zahradnikova, H. Rehulkova, P. Dvorakova, R. Nenutil, D. Valik, B. Vojtesek, L. Hernychova, MV. Novotny,
- 520 9_
- $a Analysis of N-glycans released enzymatically from patients' sera or other clinical samples may provide diagnostically and prognostically important information on human disease. Permethylation of these biomolecules simultaneously increases their hydrophobicity and substantially improves their detection parameters in the following mass spectrometric analyses. The overall procedure, from the glycan cleavage to the final mass spectrometric determinations, includes several steps involving extraction, derivatization, and purification. During these steps, certain polymeric contaminants that may have been coincidentally introduced could hamper the final measurements. To understand and counter these interferences and further fractionate or preconcentrate these glycans, we introduce here an effective microgradient chromatographic technique that employs a small reversed-phase microcolumn connected to a gas-tight microsyringe delivering a mobile-phase gradient. After loading the glycan fraction onto the microcolumn, three elution steps are recommended: (1) remove polar contaminants; (2) recover permethylated glycans for either liquid chromatography with electrospray ionization mass spectrometry or matrix-assisted laser desorption/ionization mass spectrometry; and (3) remove larger polymeric contaminants and regenerate the precolumn. We further demonstrate that the trapped second fraction can be beneficially preconcentrated and further separated to achieve matrix-assisted laser desorption/ionization mass spectrometric detection of the derivatized N-glycans up to 6300 Da. The enhanced detection capabilities for tetra-antennary N-glycans are of increasing interest in disease biomarker discovery.
- 650 _2
- $a nádorové biomarkery $x krev $7 D014408
- 650 _2
- $a chemická frakcionace $7 D005591
- 650 _2
- $a chromatografie $7 D002845
- 650 _2
- $a chromatografie kapalinová $7 D002853
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a zdraví dobrovolníci pro lékařské studie $7 D064368
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a metylace $7 D008745
- 650 _2
- $a nádory vaječníků $x krev $7 D010051
- 650 _2
- $a polysacharidy $x analýza $7 D011134
- 650 _2
- $a hmotnostní spektrometrie s elektrosprejovou ionizací $7 D021241
- 650 _2
- $a spektrometrie hmotnostní - ionizace laserem za účasti matrice $7 D019032
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Zahradnikova, Martina $u Regional Centre for Applied Molecular Oncology, Masaryk Memorial Cancer Institute, Brno, Czech Republic.
- 700 1_
- $a Rehulkova, Helena $u Department of Molecular Pathology and Biology, Faculty of Military Health Sciences, University of Defence, Hradec Kralove, Czech Republic.
- 700 1_
- $a Dvorakova, Petra $u Regional Centre for Applied Molecular Oncology, Masaryk Memorial Cancer Institute, Brno, Czech Republic.
- 700 1_
- $a Nenutil, Rudolf $u Regional Centre for Applied Molecular Oncology, Masaryk Memorial Cancer Institute, Brno, Czech Republic.
- 700 1_
- $a Valik, Dalibor $u Regional Centre for Applied Molecular Oncology, Masaryk Memorial Cancer Institute, Brno, Czech Republic.
- 700 1_
- $a Vojtesek, Borivoj $u Regional Centre for Applied Molecular Oncology, Masaryk Memorial Cancer Institute, Brno, Czech Republic.
- 700 1_
- $a Hernychova, Lenka $u Regional Centre for Applied Molecular Oncology, Masaryk Memorial Cancer Institute, Brno, Czech Republic.
- 700 1_
- $a Novotný, Miloš V., $d 1942- $u Regional Centre for Applied Molecular Oncology, Masaryk Memorial Cancer Institute, Brno, Czech Republic. Department of Chemistry, Indiana University, Bloomington, IN, USA. $7 ola200208536
- 773 0_
- $w MED00006463 $t Journal of separation science $x 1615-9314 $g Roč. 41, č. 9 (2018), s. 1973-1982
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/29392831 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20190107 $b ABA008
- 991 __
- $a 20191024095204 $b ABA008
- 999 __
- $a ok $b bmc $g 1364913 $s 1039068
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2018 $b 41 $c 9 $d 1973-1982 $e 20180306 $i 1615-9314 $m Journal of separation science $n J Sep Sci $x MED00006463
- LZP __
- $a Pubmed-20190107